Choosing Biometric Verification for Digital Therapeutics

Excluded from normalized aggregate trends after staff review: 3056 posts were attributed to March 2026; 671 shared March 14, 2026. The preceding six-month median was 13.5 posts.

Review evidence: 3,056 posts in March 2026; 671 shared March 14, 2026; preceding six-month median 13.5. Reviewed August 9, 2026.

This company's pages remain public, but its content is excluded from normalized aggregate trends. Unfiltered raw trends and advanced filtering are available to Accelerate and Lead accounts.

Digital therapeutics (DTx) are transforming healthcare by providing software-driven, evidence-based interventions for managing conditions like chronic illnesses and mental health disorders. As DTx solutions handle highly sensitive health data and directly impact patient well-being, robust biometric identity verification is essential to ensure patient safety, data integrity, and regulatory compliance. Various biometric methods are used for identity verification, including fingerprint scanning, voice recognition, iris/retina scanning, and facial recognition with liveness detection. Among these, facial recognition with advanced liveness detection stands out as the most secure and suitable option for DTx, offering high accuracy and fraud prevention capabilities. Didit, an AI-native identity platform, provides a comprehensive solution with its Free Core KYC, 1:1 Face Match, and multiple liveness detection methods, ensuring that only authorized users access sensitive therapeutic data. Didit's platform is designed for global scalability and compliance, offering real-time fraud prevention and a developer-first approach with no setup fees, making it accessible for DTx innovators.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.